Logo
F

Fractyl Health

110 employees

We believe that new approaches are needed to address obesity and type 2 diabetes to break the pattern of chronic medications and free patients from the burden of these diseases. Our goal is to improve patients’ quality of life and prevent and reverse metabolic diseases by treating their root causes in the key metabolic control organs of the gut—the duodenum and the pancreas. Learn more about our science and our company at fractylhealth.com.

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2010

Funding rounds raised

F

Fractyl Health raised undisclosed on September 15, 2022

Investors: Taiwania Capital Management Corporation and + 8 Other investors

FAQ